ArticleDrug design, development and therapy2015

Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.

X Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.